nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Paclitaxel—ovarian cancer	0.0756	0.249	CbGbCtD
Gemfibrozil—CYP3A4—Topotecan—ovarian cancer	0.062	0.204	CbGbCtD
Gemfibrozil—CYP2C9—Paclitaxel—ovarian cancer	0.0528	0.174	CbGbCtD
Gemfibrozil—CYP3A4—Vinorelbine—ovarian cancer	0.0437	0.144	CbGbCtD
Gemfibrozil—CYP3A4—Paclitaxel—ovarian cancer	0.0307	0.101	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—ovarian cancer	0.0222	0.0731	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—ovarian cancer	0.0165	0.0545	CbGbCtD
Gemfibrozil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000913	0.00168	CcSEcCtD
Gemfibrozil—Flatulence—Paclitaxel—ovarian cancer	0.000907	0.00167	CcSEcCtD
Gemfibrozil—Pruritus—Melphalan—ovarian cancer	0.000904	0.00166	CcSEcCtD
Gemfibrozil—Tension—Paclitaxel—ovarian cancer	0.000903	0.00166	CcSEcCtD
Gemfibrozil—Dysgeusia—Paclitaxel—ovarian cancer	0.000901	0.00166	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—ovarian cancer	0.000899	0.00165	CcSEcCtD
Gemfibrozil—Rhinitis—Docetaxel—ovarian cancer	0.000898	0.00165	CcSEcCtD
Gemfibrozil—Nervousness—Paclitaxel—ovarian cancer	0.000894	0.00164	CcSEcCtD
Gemfibrozil—Diarrhoea—Topotecan—ovarian cancer	0.000893	0.00164	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Docetaxel—ovarian cancer	0.000892	0.00164	CcSEcCtD
Gemfibrozil—Urticaria—Vinorelbine—ovarian cancer	0.000887	0.00163	CcSEcCtD
Gemfibrozil—Abdominal pain—Vinorelbine—ovarian cancer	0.000883	0.00162	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Docetaxel—ovarian cancer	0.00088	0.00162	CcSEcCtD
Gemfibrozil—Diarrhoea—Melphalan—ovarian cancer	0.000874	0.00161	CcSEcCtD
Gemfibrozil—Nausea—Chlorambucil—ovarian cancer	0.000871	0.0016	CcSEcCtD
Gemfibrozil—Vision blurred—Paclitaxel—ovarian cancer	0.000867	0.0016	CcSEcCtD
Gemfibrozil—Dizziness—Topotecan—ovarian cancer	0.000863	0.00159	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000857	0.00158	CcSEcCtD
Gemfibrozil—Anaemia—Paclitaxel—ovarian cancer	0.000851	0.00156	CcSEcCtD
Gemfibrozil—Angioedema—Paclitaxel—ovarian cancer	0.000841	0.00155	CcSEcCtD
Gemfibrozil—Eye disorder—Docetaxel—ovarian cancer	0.000837	0.00154	CcSEcCtD
Gemfibrozil—Vomiting—Topotecan—ovarian cancer	0.00083	0.00153	CcSEcCtD
Gemfibrozil—Vertigo—Paclitaxel—ovarian cancer	0.000827	0.00152	CcSEcCtD
Gemfibrozil—Syncope—Paclitaxel—ovarian cancer	0.000825	0.00152	CcSEcCtD
Gemfibrozil—Leukopenia—Paclitaxel—ovarian cancer	0.000824	0.00152	CcSEcCtD
Gemfibrozil—Rash—Topotecan—ovarian cancer	0.000823	0.00151	CcSEcCtD
Gemfibrozil—Dermatitis—Topotecan—ovarian cancer	0.000822	0.00151	CcSEcCtD
Gemfibrozil—Headache—Topotecan—ovarian cancer	0.000818	0.0015	CcSEcCtD
Gemfibrozil—Vomiting—Melphalan—ovarian cancer	0.000813	0.00149	CcSEcCtD
Gemfibrozil—Loss of consciousness—Paclitaxel—ovarian cancer	0.000809	0.00149	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Docetaxel—ovarian cancer	0.000808	0.00149	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—ovarian cancer	0.000807	0.00148	CcSEcCtD
Gemfibrozil—Rash—Melphalan—ovarian cancer	0.000806	0.00148	CcSEcCtD
Gemfibrozil—Dermatitis—Melphalan—ovarian cancer	0.000805	0.00148	CcSEcCtD
Gemfibrozil—Cough—Paclitaxel—ovarian cancer	0.000803	0.00148	CcSEcCtD
Gemfibrozil—Asthenia—Vinorelbine—ovarian cancer	0.000801	0.00147	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—ovarian cancer	0.000798	0.00147	CcSEcCtD
Gemfibrozil—Convulsion—Paclitaxel—ovarian cancer	0.000797	0.00147	CcSEcCtD
Gemfibrozil—Alopecia—Docetaxel—ovarian cancer	0.000792	0.00146	CcSEcCtD
Gemfibrozil—Pruritus—Vinorelbine—ovarian cancer	0.00079	0.00145	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—ovarian cancer	0.000789	0.00145	CcSEcCtD
Gemfibrozil—Mental disorder—Docetaxel—ovarian cancer	0.000785	0.00144	CcSEcCtD
Gemfibrozil—Arthralgia—Paclitaxel—ovarian cancer	0.000783	0.00144	CcSEcCtD
Gemfibrozil—Chest pain—Paclitaxel—ovarian cancer	0.000783	0.00144	CcSEcCtD
Gemfibrozil—Myalgia—Paclitaxel—ovarian cancer	0.000783	0.00144	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—ovarian cancer	0.000781	0.00144	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000778	0.00143	CcSEcCtD
Gemfibrozil—Nausea—Topotecan—ovarian cancer	0.000775	0.00143	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—ovarian cancer	0.00077	0.00142	CcSEcCtD
Gemfibrozil—Diarrhoea—Vinorelbine—ovarian cancer	0.000764	0.00141	CcSEcCtD
Gemfibrozil—Dysgeusia—Docetaxel—ovarian cancer	0.000764	0.00141	CcSEcCtD
Gemfibrozil—Nausea—Melphalan—ovarian cancer	0.000759	0.0014	CcSEcCtD
Gemfibrozil—Confusional state—Paclitaxel—ovarian cancer	0.000757	0.00139	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000751	0.00138	CcSEcCtD
Gemfibrozil—Oedema—Paclitaxel—ovarian cancer	0.000751	0.00138	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—ovarian cancer	0.000748	0.00138	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000746	0.00137	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—ovarian cancer	0.00074	0.00136	CcSEcCtD
Gemfibrozil—Shock—Paclitaxel—ovarian cancer	0.000739	0.00136	CcSEcCtD
Gemfibrozil—Dizziness—Vinorelbine—ovarian cancer	0.000738	0.00136	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000738	0.00136	CcSEcCtD
Gemfibrozil—Nervous system disorder—Paclitaxel—ovarian cancer	0.000737	0.00135	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000735	0.00135	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—ovarian cancer	0.00073	0.00134	CcSEcCtD
Gemfibrozil—Skin disorder—Paclitaxel—ovarian cancer	0.000729	0.00134	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000723	0.00133	CcSEcCtD
Gemfibrozil—Anaemia—Docetaxel—ovarian cancer	0.000721	0.00133	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—ovarian cancer	0.000717	0.00132	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—ovarian cancer	0.000713	0.00131	CcSEcCtD
Gemfibrozil—Vomiting—Vinorelbine—ovarian cancer	0.00071	0.00131	CcSEcCtD
Gemfibrozil—Rash—Vinorelbine—ovarian cancer	0.000704	0.0013	CcSEcCtD
Gemfibrozil—Dermatitis—Vinorelbine—ovarian cancer	0.000703	0.00129	CcSEcCtD
Gemfibrozil—Headache—Vinorelbine—ovarian cancer	0.000699	0.00129	CcSEcCtD
Gemfibrozil—Syncope—Docetaxel—ovarian cancer	0.000699	0.00129	CcSEcCtD
Gemfibrozil—Leukopenia—Docetaxel—ovarian cancer	0.000698	0.00128	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—ovarian cancer	0.000692	0.00127	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000689	0.00127	CcSEcCtD
Gemfibrozil—Loss of consciousness—Docetaxel—ovarian cancer	0.000686	0.00126	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—ovarian cancer	0.000685	0.00126	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000684	0.00126	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—ovarian cancer	0.000683	0.00126	CcSEcCtD
Gemfibrozil—Cough—Docetaxel—ovarian cancer	0.000681	0.00125	CcSEcCtD
Gemfibrozil—Convulsion—Docetaxel—ovarian cancer	0.000676	0.00124	CcSEcCtD
Gemfibrozil—Paraesthesia—Paclitaxel—ovarian cancer	0.000674	0.00124	CcSEcCtD
Gemfibrozil—Somnolence—Paclitaxel—ovarian cancer	0.000668	0.00123	CcSEcCtD
Gemfibrozil—Arthralgia—Docetaxel—ovarian cancer	0.000664	0.00122	CcSEcCtD
Gemfibrozil—Myalgia—Docetaxel—ovarian cancer	0.000664	0.00122	CcSEcCtD
Gemfibrozil—Chest pain—Docetaxel—ovarian cancer	0.000664	0.00122	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—ovarian cancer	0.000663	0.00122	CcSEcCtD
Gemfibrozil—Nausea—Vinorelbine—ovarian cancer	0.000663	0.00122	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—ovarian cancer	0.000662	0.00122	CcSEcCtD
Gemfibrozil—Dyspepsia—Paclitaxel—ovarian cancer	0.000661	0.00122	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00066	0.00121	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000659	0.00121	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—ovarian cancer	0.000656	0.00121	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—ovarian cancer	0.000654	0.0012	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000648	0.00119	CcSEcCtD
Gemfibrozil—Fatigue—Paclitaxel—ovarian cancer	0.000647	0.00119	CcSEcCtD
Gemfibrozil—Pain—Paclitaxel—ovarian cancer	0.000642	0.00118	CcSEcCtD
Gemfibrozil—Constipation—Paclitaxel—ovarian cancer	0.000642	0.00118	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—ovarian cancer	0.000642	0.00118	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000638	0.00117	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000637	0.00117	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—ovarian cancer	0.000637	0.00117	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—ovarian cancer	0.000637	0.00117	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—ovarian cancer	0.000632	0.00116	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—ovarian cancer	0.000626	0.00115	CcSEcCtD
Gemfibrozil—Nervous system disorder—Docetaxel—ovarian cancer	0.000624	0.00115	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—ovarian cancer	0.000623	0.00115	CcSEcCtD
Gemfibrozil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000619	0.00114	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—ovarian cancer	0.000618	0.00114	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000614	0.00113	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—ovarian cancer	0.000612	0.00113	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000611	0.00112	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—ovarian cancer	0.000607	0.00112	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—ovarian cancer	0.000606	0.00111	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—ovarian cancer	0.000605	0.00111	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—ovarian cancer	0.000601	0.00111	CcSEcCtD
Gemfibrozil—Urticaria—Paclitaxel—ovarian cancer	0.000597	0.0011	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000594	0.00109	CcSEcCtD
Gemfibrozil—Abdominal pain—Paclitaxel—ovarian cancer	0.000594	0.00109	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000589	0.00108	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00058	0.00107	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—ovarian cancer	0.000572	0.00105	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—ovarian cancer	0.000566	0.00104	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—ovarian cancer	0.000565	0.00104	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—ovarian cancer	0.000561	0.00103	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—ovarian cancer	0.00056	0.00103	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000556	0.00102	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00055	0.00101	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00055	0.00101	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—ovarian cancer	0.000549	0.00101	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000545	0.001	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—ovarian cancer	0.000544	0.001	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—ovarian cancer	0.000544	0.001	CcSEcCtD
Gemfibrozil—Asthenia—Paclitaxel—ovarian cancer	0.000539	0.000991	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—ovarian cancer	0.000534	0.000982	CcSEcCtD
Gemfibrozil—Pruritus—Paclitaxel—ovarian cancer	0.000531	0.000977	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—ovarian cancer	0.000529	0.000974	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—ovarian cancer	0.000525	0.000965	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—ovarian cancer	0.000523	0.000961	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000521	0.000958	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—ovarian cancer	0.000518	0.000954	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—ovarian cancer	0.000516	0.00095	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—ovarian cancer	0.000515	0.000948	CcSEcCtD
Gemfibrozil—Diarrhoea—Paclitaxel—ovarian cancer	0.000514	0.000945	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—ovarian cancer	0.000511	0.00094	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000504	0.000927	CcSEcCtD
Gemfibrozil—Abdominal pain—Docetaxel—ovarian cancer	0.000503	0.000926	CcSEcCtD
Gemfibrozil—Dizziness—Paclitaxel—ovarian cancer	0.000497	0.000914	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—ovarian cancer	0.000496	0.000912	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—ovarian cancer	0.000494	0.000909	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—ovarian cancer	0.00049	0.000901	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—ovarian cancer	0.000486	0.000895	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—ovarian cancer	0.00048	0.000882	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—ovarian cancer	0.000478	0.000879	CcSEcCtD
Gemfibrozil—Vomiting—Paclitaxel—ovarian cancer	0.000478	0.000878	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—ovarian cancer	0.000477	0.000877	CcSEcCtD
Gemfibrozil—Rash—Paclitaxel—ovarian cancer	0.000474	0.000871	CcSEcCtD
Gemfibrozil—Dermatitis—Paclitaxel—ovarian cancer	0.000473	0.00087	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—ovarian cancer	0.000473	0.00087	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—ovarian cancer	0.000473	0.00087	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—ovarian cancer	0.000472	0.000868	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—ovarian cancer	0.000471	0.000866	CcSEcCtD
Gemfibrozil—Headache—Paclitaxel—ovarian cancer	0.00047	0.000866	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—ovarian cancer	0.000462	0.000851	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—ovarian cancer	0.000459	0.000845	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—ovarian cancer	0.000459	0.000844	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—ovarian cancer	0.000457	0.00084	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—ovarian cancer	0.000456	0.000839	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—ovarian cancer	0.00045	0.000828	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—ovarian cancer	0.00045	0.000828	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—ovarian cancer	0.000448	0.000824	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—ovarian cancer	0.000448	0.000824	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—ovarian cancer	0.000448	0.000824	CcSEcCtD
Gemfibrozil—Nausea—Paclitaxel—ovarian cancer	0.000446	0.000821	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000445	0.000818	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—ovarian cancer	0.000437	0.000805	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—ovarian cancer	0.000437	0.000803	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—ovarian cancer	0.000436	0.000802	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—ovarian cancer	0.000436	0.000801	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—ovarian cancer	0.000433	0.000796	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—ovarian cancer	0.000429	0.00079	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—ovarian cancer	0.000429	0.00079	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000428	0.000787	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—ovarian cancer	0.000425	0.000781	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—ovarian cancer	0.000422	0.000777	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—ovarian cancer	0.000422	0.000776	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—ovarian cancer	0.000421	0.000775	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—ovarian cancer	0.000421	0.000774	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—ovarian cancer	0.00042	0.000773	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—ovarian cancer	0.000417	0.000767	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—ovarian cancer	0.000414	0.000762	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—ovarian cancer	0.000414	0.000762	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—ovarian cancer	0.000414	0.000762	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000412	0.000757	CcSEcCtD
Gemfibrozil—Vomiting—Docetaxel—ovarian cancer	0.000405	0.000745	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—ovarian cancer	0.000401	0.000738	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—ovarian cancer	0.000401	0.000738	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—ovarian cancer	0.000401	0.000737	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—ovarian cancer	0.000399	0.000734	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000397	0.000731	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—ovarian cancer	0.000397	0.000731	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000391	0.00072	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—ovarian cancer	0.000391	0.000719	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—ovarian cancer	0.00039	0.000717	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000389	0.000716	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—ovarian cancer	0.000386	0.00071	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—ovarian cancer	0.000386	0.000709	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—ovarian cancer	0.000382	0.000702	CcSEcCtD
Gemfibrozil—Nausea—Docetaxel—ovarian cancer	0.000378	0.000696	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—ovarian cancer	0.000378	0.000695	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000371	0.000682	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—ovarian cancer	0.00037	0.000681	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—ovarian cancer	0.000367	0.000675	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—ovarian cancer	0.000367	0.000675	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000362	0.000666	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—ovarian cancer	0.000357	0.000656	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—ovarian cancer	0.000354	0.000651	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—ovarian cancer	0.000353	0.00065	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000351	0.000646	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—ovarian cancer	0.00035	0.000643	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000343	0.000631	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—ovarian cancer	0.000343	0.00063	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—ovarian cancer	0.000341	0.000627	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—ovarian cancer	0.00034	0.000625	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—ovarian cancer	0.00034	0.000625	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—ovarian cancer	0.000339	0.000624	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000327	0.000602	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000325	0.000598	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—ovarian cancer	0.000316	0.000581	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—ovarian cancer	0.000314	0.000578	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—ovarian cancer	0.000308	0.000567	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—ovarian cancer	0.000304	0.000559	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000296	0.00193	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000294	0.00192	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Epirubicin—ovarian cancer	0.000294	0.00054	CcSEcCtD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00029	0.0019	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000287	0.00187	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYTB—ovarian cancer	0.000286	0.00187	CbGpPWpGaD
Gemfibrozil—Asthenia—Doxorubicin—ovarian cancer	0.000285	0.000524	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—ovarian cancer	0.000284	0.000522	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—ovarian cancer	0.000281	0.000517	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000279	0.00183	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000277	0.00181	CbGpPWpGaD
Gemfibrozil—Vomiting—Epirubicin—ovarian cancer	0.000273	0.000502	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—ovarian cancer	0.000272	0.0005	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—ovarian cancer	0.000271	0.000498	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—ovarian cancer	0.00027	0.000498	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—ovarian cancer	0.000269	0.000495	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—ovarian cancer	0.000263	0.000483	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—ovarian cancer	0.000255	0.000469	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—ovarian cancer	0.000253	0.000465	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—PTEN—ovarian cancer	0.000252	0.00165	CbGpPWpGaD
Gemfibrozil—Rash—Doxorubicin—ovarian cancer	0.00025	0.000461	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—ovarian cancer	0.00025	0.00046	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism—NME2—ovarian cancer	0.00025	0.00164	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—BRIP1—ovarian cancer	0.00025	0.00163	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPP1CC—ovarian cancer	0.00025	0.00163	CbGpPWpGaD
Gemfibrozil—Headache—Doxorubicin—ovarian cancer	0.000249	0.000458	CcSEcCtD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000243	0.00159	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000238	0.00156	CbGpPWpGaD
Gemfibrozil—Nausea—Doxorubicin—ovarian cancer	0.000236	0.000434	CcSEcCtD
Gemfibrozil—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	0.000236	0.00154	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000233	0.00152	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IL6—ovarian cancer	0.000223	0.00146	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000219	0.00143	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—YAP1—ovarian cancer	0.000215	0.00141	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000212	0.00139	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.00021	0.00138	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ESR1—ovarian cancer	0.000209	0.00136	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000208	0.00136	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000201	0.00131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000201	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MET—ovarian cancer	0.000197	0.00129	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000197	0.00129	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6ST—ovarian cancer	0.000193	0.00126	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000192	0.00125	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000189	0.00124	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PGR—ovarian cancer	0.000188	0.00123	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000182	0.00119	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000182	0.00119	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PARP1—ovarian cancer	0.000175	0.00114	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000173	0.00113	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—ovarian cancer	0.000172	0.00113	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—YAP1—ovarian cancer	0.000167	0.00109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000167	0.00109	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000166	0.00108	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000165	0.00108	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP2—ovarian cancer	0.000164	0.00107	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000164	0.00107	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000162	0.00106	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000162	0.00106	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000162	0.00106	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYTB—ovarian cancer	0.000161	0.00105	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—IL6—ovarian cancer	0.000158	0.00103	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000158	0.00103	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000156	0.00102	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000154	0.00101	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000151	0.000984	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.00015	0.000984	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.00015	0.000984	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000148	0.000967	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000146	0.000952	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ERBB2—ovarian cancer	0.000144	0.000942	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NME2—ovarian cancer	0.000144	0.00094	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000142	0.000929	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPP2R1A—ovarian cancer	0.000142	0.000927	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	0.000141	0.000921	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—BRIP1—ovarian cancer	0.000141	0.000921	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—FASN—ovarian cancer	0.000137	0.000892	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SLC5A5—ovarian cancer	0.000134	0.000878	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SLC2A1—ovarian cancer	0.00013	0.000848	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NME2—ovarian cancer	0.000128	0.000839	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000127	0.00083	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000127	0.000827	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000126	0.000827	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CTNNB1—ovarian cancer	0.000126	0.000824	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000125	0.000816	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1B1—ovarian cancer	0.000124	0.000813	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—ovarian cancer	0.000124	0.000808	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000123	0.000806	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000122	0.000797	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000121	0.00079	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NME2—ovarian cancer	0.000117	0.000765	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—ovarian cancer	0.000111	0.000725	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPP2R1A—ovarian cancer	0.00011	0.000721	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—STAT3—ovarian cancer	0.00011	0.000718	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.00011	0.000717	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—NRAS—ovarian cancer	0.00011	0.000717	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000109	0.000711	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—ovarian cancer	0.000108	0.000709	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MAPK3—ovarian cancer	0.000105	0.000686	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000103	0.000671	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ABCB1—ovarian cancer	0.000102	0.000669	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TYMS—ovarian cancer	0.000101	0.000657	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR1—ovarian cancer	0.0001	0.000656	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NME2—ovarian cancer	0.0001	0.000654	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MAPK1—ovarian cancer	9.99e-05	0.000653	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EGFR—ovarian cancer	9.99e-05	0.000653	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.94e-05	0.00065	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.93e-05	0.000649	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—YAP1—ovarian cancer	9.45e-05	0.000618	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—ovarian cancer	9.44e-05	0.000617	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.35e-05	0.000611	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYTB—ovarian cancer	9.26e-05	0.000606	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.05e-05	0.000592	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.87e-05	0.00058	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.48e-05	0.000554	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYTB—ovarian cancer	8.27e-05	0.00054	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.22e-05	0.000537	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CAV1—ovarian cancer	8.1e-05	0.00053	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BRIP1—ovarian cancer	8.1e-05	0.000529	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPP1CC—ovarian cancer	8.1e-05	0.000529	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.09e-05	0.000529	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.08e-05	0.000528	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—ovarian cancer	8.02e-05	0.000524	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.74e-05	0.000506	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NME2—ovarian cancer	7.72e-05	0.000504	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—FASN—ovarian cancer	7.71e-05	0.000504	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—ovarian cancer	7.68e-05	0.000502	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	7.58e-05	0.000495	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYTB—ovarian cancer	7.54e-05	0.000493	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CG—ovarian cancer	7.38e-05	0.000482	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.37e-05	0.000482	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	7.32e-05	0.000478	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPP1CC—ovarian cancer	7.23e-05	0.000472	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BRIP1—ovarian cancer	7.23e-05	0.000472	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.17e-05	0.000468	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—AKT1—ovarian cancer	7.08e-05	0.000463	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	7.02e-05	0.000459	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.91e-05	0.000452	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	6.59e-05	0.000431	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BRIP1—ovarian cancer	6.59e-05	0.000431	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CD—ovarian cancer	6.49e-05	0.000424	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYTB—ovarian cancer	6.44e-05	0.000421	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.3e-05	0.000412	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	6.22e-05	0.000407	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.19e-05	0.000405	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.9e-05	0.000386	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ABCB1—ovarian cancer	5.78e-05	0.000378	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TYMS—ovarian cancer	5.68e-05	0.000371	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CB—ovarian cancer	5.66e-05	0.00037	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.63e-05	0.000368	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.63e-05	0.000368	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—YAP1—ovarian cancer	5.43e-05	0.000355	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.38e-05	0.000351	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MAPK3—ovarian cancer	5.37e-05	0.000351	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.27e-05	0.000344	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—ovarian cancer	5.22e-05	0.000341	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYTB—ovarian cancer	4.97e-05	0.000325	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—ovarian cancer	4.89e-05	0.000319	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—YAP1—ovarian cancer	4.85e-05	0.000317	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.8e-05	0.000314	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.8e-05	0.000314	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.73e-05	0.000309	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CAV1—ovarian cancer	4.57e-05	0.000299	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—FASN—ovarian cancer	4.43e-05	0.000289	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—YAP1—ovarian cancer	4.42e-05	0.000289	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.37e-05	0.000286	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.37e-05	0.000286	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A5—ovarian cancer	4.36e-05	0.000285	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.35e-05	0.000284	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.35e-05	0.000284	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.22e-05	0.000276	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC2A1—ovarian cancer	4.21e-05	0.000275	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	4.17e-05	0.000272	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.12e-05	0.000269	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.1e-05	0.000268	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—ovarian cancer	4.03e-05	0.000264	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FASN—ovarian cancer	3.95e-05	0.000258	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.89e-05	0.000254	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.85e-05	0.000251	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—YAP1—ovarian cancer	3.78e-05	0.000247	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.75e-05	0.000245	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.74e-05	0.000244	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.68e-05	0.00024	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	3.66e-05	0.000239	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—ovarian cancer	3.62e-05	0.000237	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FASN—ovarian cancer	3.6e-05	0.000236	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.6e-05	0.000235	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	3.58e-05	0.000234	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.56e-05	0.000233	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.54e-05	0.000232	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—ovarian cancer	3.45e-05	0.000225	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3.42e-05	0.000224	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.35e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—ovarian cancer	3.32e-05	0.000217	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.29e-05	0.000215	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.28e-05	0.000215	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMS—ovarian cancer	3.26e-05	0.000213	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.19e-05	0.000209	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	3.19e-05	0.000209	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.18e-05	0.000208	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FASN—ovarian cancer	3.08e-05	0.000201	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.03e-05	0.000198	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.96e-05	0.000194	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.93e-05	0.000191	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—YAP1—ovarian cancer	2.92e-05	0.000191	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMS—ovarian cancer	2.91e-05	0.00019	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.91e-05	0.00019	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.9e-05	0.000189	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.86e-05	0.000187	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—ovarian cancer	2.82e-05	0.000184	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.8e-05	0.000183	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—ovarian cancer	2.76e-05	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.7e-05	0.000177	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMS—ovarian cancer	2.65e-05	0.000173	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAV1—ovarian cancer	2.63e-05	0.000172	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.51e-05	0.000164	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.49e-05	0.000163	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.48e-05	0.000162	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.39e-05	0.000156	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FASN—ovarian cancer	2.38e-05	0.000155	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAV1—ovarian cancer	2.35e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.34e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.31e-05	0.000151	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMS—ovarian cancer	2.27e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.26e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.24e-05	0.000146	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.16e-05	0.000141	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAV1—ovarian cancer	2.14e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.14e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.1e-05	0.000138	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.04e-05	0.000134	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.95e-05	0.000127	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.95e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.92e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.88e-05	0.000123	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.83e-05	0.00012	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAV1—ovarian cancer	1.83e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.78e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMS—ovarian cancer	1.75e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.75e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.71e-05	0.000112	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.66e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.64e-05	0.000107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.59e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—ovarian cancer	1.58e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.49e-05	9.76e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.46e-05	9.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—ovarian cancer	1.41e-05	9.25e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAV1—ovarian cancer	1.41e-05	9.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—ovarian cancer	1.29e-05	8.43e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.28e-05	8.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.28e-05	8.34e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.13e-05	7.38e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.12e-05	7.31e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—ovarian cancer	1.1e-05	7.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—ovarian cancer	9.98e-06	6.52e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.85e-06	6.43e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—ovarian cancer	9.13e-06	5.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	9.1e-06	5.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—ovarian cancer	8.51e-06	5.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—ovarian cancer	8.15e-06	5.33e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.78e-06	5.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—ovarian cancer	7.43e-06	4.86e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—ovarian cancer	6.35e-06	4.15e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6e-06	3.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—ovarian cancer	4.9e-06	3.2e-05	CbGpPWpGaD
